Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 55 results found. Search for [ biotech-based drugs ]

Results 1 to 21 of 55
PTI
April 30, 2019



PTI
January 7, 2019



PTI
January 7, 2019



Rakesh K Mishra
New Delhi, December 25, 2018
\"Large-scale genome sequencing and correlating the DNA signatures with specific disease or drug sensitivity will allow clinicians to specify personalised treatment,\" says Rakesh K Mishra, Director, Centre for Cellular and Molecular Biology.


PTI
December 7, 2018
Roshni Nadar Malhotra, Kiran Mazumdar-Shaw, Shobhana Bhartia and Priyanka Chopra have been named among the world's 100 most powerful women by Forbes


PTI
December 6, 2018



PTI
December 6, 2018



PTI
October 17, 2018



P.B. Jayakumar
New Delhi, April 30, 2018
Drug companies are moving up the value chain, transforming into complex generic manufacturers with high end R&D facilities.


Joe C Mathew
New Delhi, February 13, 2018
US based drug makers lobby group Pharmaceutical Research and Manufacturers of America (PhRMA) has complained that the positive signals given by India


E. Kumar Sharma
New Delhi, January 10, 2018
By following the strategy of doing a few things well, V.C. Nannapaneni has helped Natco Pharma carve out a space for itself.


P.B. Jayakumar
New Delhi, December 11, 2017
Margin erosion and regulatory hurdles are hitting Indian pharma companies hard in their biggest market.


E Kumar Sharma
New Delhi, September 15, 2017
India has taken a lead here and going by the official figures, there are around 24 cancer biosimilar drugs in all that have already been approved by the Indian regulator since 2011.


By Sumant Banerji
Delhi, March 4, 2017
Brawn Biotechs foray into export markets has turned around the fortunes of the company.


By E Kumar Sharma
Delhi, August 19, 2016
The fact that the $8-billion Fosun Group was keen on the US market makes the deal special, given that 62 per cent of Gland Pharma's revenues of $169 million in 2015 came from the US, compared to 16 per cent from India and the rest from other geographies.


By E. Kumar Sharma
Delhi, July 23, 2016
Indian drug makers are slugging it out with Big Pharma over launch of biosimilars. Will they be able to hold their fort in this emerging space?


By E. Kumar Sharma
Delhi, May 9, 2016
It's ancient, pesky, and persistent. Its hum can spell impending doom. But the ubiquitous mosquito also drills a hole in your pocket triggering demand for hospitals, clinics, diagnostic kits, even some FMCG products. Not to forget the money going into R&D for medicines.


By E. Kumar Sharma
March 29, 2016
Dr. Reddy's Laboratories and XenoPort, Inc. announced that they have entered into a license agreement pursuant to which it will be granted exclusive US rights for the development and commercialization of XenoPort's clinical-stage oral entity.


PB Jayakumar
December 30, 2015
Year 2015 should be regarded as a good year for patients worldwide as the USFDA has given approvals for 45 New Molecular Entity and New Therapeutic Biological Products.


E. Kumar Sharma
August 14, 2015
The Indian drug firms have joined the global fight against antibiotic-resistant bacteria. The good news is that they are steadily moving ahead.


PAGES 1 OF 3  123